Current Drug Targets
Title:Editorial (Thematic Issue: Protection, Repair and Regeneration of Achybreaky Heart)
Volume: 16 Issue: 8
Author(s): Pasquale Pagliaro and Claudia Penna
Affiliation:
Export Options
About this article
Cite this article as:
Pagliaro Pasquale and Penna Claudia, Editorial (Thematic Issue: Protection, Repair and Regeneration of Achybreaky Heart), Current Drug Targets 2015; 16 (8) . https://dx.doi.org/10.2174/1389450116999150727123348
DOI https://dx.doi.org/10.2174/1389450116999150727123348 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Atherogenesis in Renal Patients: A Model of Vascular Disease?
Current Vascular Pharmacology microRNA Regulation as a Therapeutic Strategy for Cardiovascular Disease
Current Drug Targets Calcium Homeostasis and Kinetics in Heart Failure
Medicinal Chemistry Targeting Resveratrol to Mitochondria for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery The Genetics of Small-Vessel Disease
Current Medicinal Chemistry Mitochondrially Targeted Antioxidants for the Treatment of Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Editorial (Thematic Issue: Modifying Cardiovascular Risk Factors: Current Opinion and Future Trends)
Current Pharmaceutical Design Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches
Current Pediatric Reviews Mouse Models of Autoimmune Diseases - Autoimmune Myocarditis
Current Pharmaceutical Design An Increasing Incidence of Treatment Resistance in Hypertension?
Current Drug Therapy Inherited Muscle Diseases Towards Improvements of the Mouse Model Catalogue
Current Genomics Parathyroid Hormone and Heart Failure: Novel Biomarker Strategy
Endocrine, Metabolic & Immune Disorders - Drug Targets Trimetazidine: Does it Actually Reduce QT Dispersion After First Acute Myocardial Infarction?
Current Drug Therapy Clozapine Safety, 40 Years Later
Current Drug Safety Recent Advances in the Development of MMPIs and APNIs Based on the Pyrrolidine Platforms
Mini-Reviews in Medicinal Chemistry Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function?
Current Drug Targets Genetics and Vaccines in the Era of Personalized Medicine
Current Genomics Heat Shock Protein-60 and Risk for Cardiovascular Disease
Current Pharmaceutical Design The Vectorcardiogram and the Main Dromotropic Disturbances
Current Cardiology Reviews Postponing Motherhood: A Demographic and Contemporary Issue
Current Women`s Health Reviews